Latest news with #DeepSouth
Yahoo
6 days ago
- Climate
- Yahoo
When will Alabama cool off? Farmers' Almanac offers a hint at fall relief. What to know
We're only six days into summer officially, and fall can't come soon enough. Unfortunately, it might take time. With heat indexes soaring and humidity persisting well into June, many across the state are yearning for cooler temperatures and crisp mornings. The Farmer's Almanac suggests relief is on its way, eventually. Here's when Alabama residents can expect to feel the cooler temperatures across the state. Don't be surprised if summer lingers into late October. Fall in Alabama is expected to arrive with a cooler, wetter punch this year. The Farmers' Almanac predicts a cooler, stormier season across the South, with more cloud coverage than usual. But Halloween lovers can rejoice as it is expected to be dry and clear for the evening. A potential La Niña twist could extend storm season into November. As the Farmer's Almanac predicts, Alabama's summer heat isn't going anywhere anytime soon. A new three-month outlook from the National Weather Service indicates that most of the state is likely to experience slightly above-average temperatures through September. Far south and southeastern areas of the state will feel even hotter, with a stronger chance of above-normal heat lingering into early fall. The maximum temperature recorded in the state occurred on September 6, 1925, in Centerville, when temperatures soared to 112 degrees. Here are the highest recorded temperatures from cities across the state: Montgomery: 107 degrees on July 7, 1881 Tuscaloosa: 107 on Aug. 29, 2000 Gadsden: 106 on June 30, 2012 Birmingham: 107 on July 29, 1930 Dothan: 105 on July 2, 2009 Mobile: 106 on Aug. 23, 2023 Huntsville: 106 on June 29, 2012 Jennifer Lindahl is a Breaking and Trending Reporter for the Deep South Connect Team for Gannett/USA Today. Connect with her on X @jenn_lindahl and email at jlindahl@ This article originally appeared on Montgomery Advertiser: When will fall arrive in Alabama? Old Farmer's Almanac forecast
Vogue
24-06-2025
- Vogue
What My Father's Career in Crime Taught Me About Resilience
When I was 15, I loved escaping the heavy, wet heat of the Florida panhandle to stand in the chilly darkroom of my nighttime photography class, watching pictures from my father's hippie days slowly sharpen, an unknowable life revealing itself under the red light. For years, Dad had worked long hours while I was busy becoming a teenager. I moved in with him when I was 14, shortly after his split from my mom. When I found three rolls of undeveloped film at the back of his closet, I registered for a dual-enrollment photography class through my high school. Dad drove me there and back every Wednesday. One night, on the way home, he saw an advertisement on the Applebee's marquee: 2-for-1 steaks with a side! Once we were seated, I laid the photos out between us. In one, a woman with a short skirt and a crocheted, triangular bra top stared straight at the camera, biting her lip. In others, strangers stood talking or sat playing guitars or harmonicas, most wearing bell bottoms, smoke rising softly out of their mouths. Dad said, 'You know how I used to say, 'Before you were born, I was a pirate'?' I nodded. He tapped on the stack of pictures. 'It started around this time.' Over cheap steaks and wilted vegetables, my dad explained that his life in crime started in the late 1960s. First it was rolling barrels of marijuana off boats in the Port of New Orleans; later, he graduated to captaining the ships. Then he got his pilot's license to fly cocaine from South America into the Deep South. 'The point is, I made those mistakes so you wouldn't have to,' he said. 'Drugs are dangerous—and the reason I'll never meet my grandkids.' I stared, blinking, not really believing his wild stories—and certainly not realizing that the Hepatitis C my dad contracted from those pirate days would end his life a few months later. After he passed, I found his fake IDs, birth certificates, and old pilot's license. I sat on his bedroom floor, sorting through the artifacts as the sunset threw pink light across the whole room, my body, and the keys to the mystery of how a poor kid from the boiling, low-slung beaches of the rural Gulf Coast made his way to South American jungles, where he smiled beside international smugglers while wielding a machete the way so many other dads show off their daily catches with their fishing buddies.
Yahoo
17-06-2025
- Health
- Yahoo
FILAMENT HEALTH ENTERS INTO EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF ALABAMA AT BIRMINGHAM FOR DATA FROM A CLINICAL TRIAL OF PSILOCYBIN FOR THE TREATMENT OF COCAINE USE DISORDER
The data supports Filament's PEX010 drug development program targeting stimulant use disorders PEX010 is a first-in-class botanical psilocybin drug candidate currently under investigation in 52 clinical trials worldwide for 14 mental health indications VANCOUVER, BC, June 17, 2025 /CNW/ - Filament Health Corp. (OTC: FLHLF) ("Filament" or the "Company"), a clinical–stage natural psychedelic drug development company, today announced that it has entered into an exclusive global license agreement with the University of Alabama at Birmingham (UAB) for intellectual property related to a recently completed Phase 2 placebo-controlled clinical trial of psilocybin as a treatment for cocaine use disorder (CUD). The study investigated the safety and efficacy of a single-dose of psilocybin compared to placebo comparator in 40 adult patients with severe CUD. The trial was led by Principal Investigator Peter Hendricks, Ph.D., University Professor and Heersink Endowed Chair of Psychiatry at the UAB Department of Psychiatry and Behavioral Neurobiology, and a globally recognized expert in psychedelic-assisted therapies for addiction. "The results of the study demonstrated that psilocybin was well-tolerated and that a single dose resulted in a significant and durable reduction in cocaine use among people with CUD who were representative of cocaine users from the Deep South region of the United States. This is notable as most psychedelic trials fail to recruit participants representative of the population of those who could benefit from care.," said Dr. Hendricks. "We expect to have our data published in a peer-reviewed journal later this year and are excited to contribute to the science and possibly help bring to the clinic a promising treatment for cocaine and other stimulant use disorders in the future." Filament has obtained rights to access and use the data, know-how, and associated intellectual property from the clinical study, in furtherance of the Company's own proprietary development programs in stimulant use disorders. The partnership will also enable Dr. Hendricks to serve as an advisor to Filament Health and to advance research into other substance use conditions. "This agreement marks an important step in our mission to advance PEX010 and our other programs for the treatment of patients with stimulant use disorders," said Benjamin Lightburn, Co-Founder and Chief Executive Officer of Filament. "We are a leading developer of psychedelic drug candidates for substance use disorders and other mental health conditions. The positive data from Dr. Hendricks' trial, as well as his knowledge of clinical practices and ongoing counsel, will be significant assets in facilitating the advancement of our research." ABOUT FILAMENT HEALTH (OTC:FLHLF)Filament Health is a clinical-stage natural psychedelic drug development company. We believe that safe, standardized, naturally-derived psychedelic medicines can improve the lives of many, and our mission is to see them in the hands of everyone who needs them as soon as possible. Filament's platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines for clinical development. We are paving the way with the first-ever natural psychedelic drug candidates. Learn more at and on Twitter, Instagram, and LinkedIn. FORWARD LOOKING INFORMATIONCertain statements and information contained in this press release and the documents referred to herein may constitute "forward–looking statements" and "forward–looking information," respectively, under Canadian securities legislation. Generally, forward–looking information can be identified by the use of forward–looking terminology such as, "expect", "anticipate", "continue", "estimate", "may", "will", "should", "believe", "intends", "forecast", "plans", "guidance" and similar expressions are intended to identify forward–looking statements or information. The forward–looking statements are not historical facts, but reflect the current expectations of management of Filament regarding future results or events and are based on information currently available to them. Certain material factors and assumptions were applied in providing these forward–looking statements. Forward–looking statements regarding the Company are based on the Company's estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of Filament to be materially different from those expressed or implied by such forward–looking statements or forward–looking information, including the timing and results of clinical trials, the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary regulatory, court and shareholders approvals; the ability of the parties to satisfy, in a timely manner, the other conditions to the completion of the proposed business combination; other expectations and assumptions concerning the transactions contemplated in the proposed business combination; the available funds of the parties and the anticipated use of such funds; the availability of financing opportunities; legal and regulatory risks inherent in the psychedelic drug development industry; risks associated with economic conditions, dependence on management and currency risk; risks relating to U.S. regulatory landscape; risks relating to anti-money laundering laws and regulation; other governmental and environmental regulation; public opinion and perception of the psychedelic drug development industry; risks related to the economy generally; risk of litigation; conflicts of interest; risks relating to certain remedies being limited and the difficulty of enforcement of judgments and effect service outside of Canada; and risks related to future acquisitions or dispositions. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward– looking statements and forward–looking information. Filament will not update any forward–looking statements or forward–looking information that are incorporated by reference herein, except as required by applicable securities laws. SOURCE Filament Health Corp. View original content to download multimedia: Sign in to access your portfolio
Yahoo
04-06-2025
- Business
- Yahoo
Zaxby's brings back milkshakes. What flavors are coming? When does half price end?
Need a sweet treat with your Zax Snacks? An old favorite is back at limited stores with more coming. Zaxby's is bringing milkshakes back to its menu after being gone for seven years. Here's what we know, including how to get them in Georgia: The milkshakes are already slowly rolling out to stores, with some already selling it. According to the company's Monday news release, they are expected to be nationwide by June. Zaxby's said, as of this summer, the milkshakes will be on menus permanently. Meaning you don't have to worry about getting them before they are gone. The milkshakes are hand spun and topped with whipped cream, colorful sprinkles, and a Maraschino cherry. They come in vanilla, chocolate, strawberry, and "Birthday Cake" with flavors of baked cake, buttercream, and French vanilla. Zaxby's milkshakes typically start at about $5, but now until June 1, they are being sold at half price: $2.50. You don't need to be part of Zaxby's rewards program to get the sale. All milkshakes are available in only small. Zaxby's online store locator has started marking restaurants with a milkshake icon to identify whether or not they sell the shakes. Currently, they are sold all over Atlanta, Augusta, Athens, and Macon. Savannah currently only has one selling it at 8040 White Bluff Rd. Columbus has a small handful on Auburn Avenue, Bradley Park Drive, Ingersoll Street, Schomburg Road, and Ruffie Way. Miguel Legoas is a Deep South Connect Team Reporter for Gannett/USA Today. Find him on X and Instagram @miguelegoas and email at mlegoas@ This article originally appeared on Savannah Morning News: Zaxby's milkshakes: Price, flavors, and Georgia locations selling them
RNZ News
01-06-2025
- General
- RNZ News
ANZ Premiership live updates: Steel v Pulse
The Pulse are on a roll after a solid victory over the Stars last weekend, while the Steel will be hurting after their one goal loss to the Mystics. However, they're back in front of their Invercargill faithful for what promises to be an exciting encounter in the deep south. Play starts at 4pm NZT. Follow all the action with RNZ's live blog:
